Apicore US LLC, headquartered in New Jersey, USA, is a leading process R&D and API manufacturing service provider for the worldwide pharmaceutical industry. Apicore offers a wide portfolio of services ranging from API’s for the generic industry to custom synthesis for early phase pharmaceutical research, and branded products.
Apicore has 2 USFDA-approved facilities. In the USA, the Somerset, NJ facility can produce a few grams up to 200Kg volumes and in India, the Vadodara, Gujarat facility can produce a few Kg to a few metric tons up to 60 MT/yearly. Both facilities are equipped with state-of-the-art analytical and research capabilities.
The Human Resource component sets Apicore apart from the competition. While our two locations work smoothly as one, they also can operate independently of each other, with both facilities each housing R&D, QA, QC, and Manufacturing services. This combination promotes an exchange of ideas as well as production resources that continuously benefits our clients. Our managing partners, responsible for the group’s business operations, have a combined experience of greater than 60 years in the pharmaceutical business which encompasses small, mid and large pharmaceutical companies throughout the world.
Our Mission is to
Develop, manufacture and deliver API’s at market competitive costs to a wide range of customers across the globe while providing the highest quality and regulatory support. Be first to market and establish the leading market share position for the majority of API’s in our portfolio.
Apicore US LLC started operations in 2004.
Apicore Pharmaceuticals Pvt. Ltd., a wholly owned subsidiary of Apicore US LLC, commenced operations in 2006.